CVS Health Co. (NYSE:CVS) Shares Bought by Meeder Asset Management Inc.

Meeder Asset Management Inc. boosted its holdings in CVS Health Co. (NYSE:CVS) by 2,925.0% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 10,285 shares of the pharmacy operator’s stock after buying an additional 9,945 shares during the quarter. Meeder Asset Management Inc.’s holdings in CVS Health were worth $647,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also made changes to their positions in CVS. OneAscent Financial Services LLC purchased a new stake in shares of CVS Health during the 3rd quarter worth approximately $309,000. Pathstone Holdings LLC grew its holdings in shares of CVS Health by 2.0% during the third quarter. Pathstone Holdings LLC now owns 222,285 shares of the pharmacy operator’s stock worth $13,977,000 after purchasing an additional 4,432 shares during the last quarter. Amara Financial LLC. purchased a new stake in shares of CVS Health in the 3rd quarter valued at about $354,000. MidAtlantic Capital Management Inc. acquired a new stake in shares of CVS Health in the 3rd quarter valued at about $25,000. Finally, Strengthening Families & Communities LLC increased its position in CVS Health by 13.3% during the third quarter. Strengthening Families & Communities LLC now owns 27,218 shares of the pharmacy operator’s stock worth $1,711,000 after buying an additional 3,202 shares during the period. 80.66% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of equities analysts have recently issued reports on CVS shares. Barclays lowered their target price on shares of CVS Health from $75.00 to $71.00 and set an “overweight” rating on the stock in a research report on Thursday, November 7th. StockNews.com downgraded shares of CVS Health from a “hold” rating to a “sell” rating in a research note on Thursday, November 14th. Deutsche Bank Aktiengesellschaft dropped their price target on CVS Health from $64.00 to $63.00 and set a “hold” rating on the stock in a research report on Friday, August 9th. Mizuho lowered their target price on CVS Health from $73.00 to $66.00 and set an “outperform” rating on the stock in a research note on Thursday, October 24th. Finally, Wells Fargo & Company upgraded CVS Health from an “equal weight” rating to an “overweight” rating and upped their price target for the stock from $60.00 to $66.00 in a research note on Monday. One equities research analyst has rated the stock with a sell rating, seven have issued a hold rating and thirteen have issued a buy rating to the company. According to data from MarketBeat, CVS Health currently has a consensus rating of “Moderate Buy” and a consensus target price of $72.78.

CVS Health Price Performance

CVS stock opened at $55.82 on Wednesday. The firm has a 50 day moving average of $59.18 and a 200-day moving average of $58.60. The company has a market cap of $70.24 billion, a price-to-earnings ratio of 14.17, a PEG ratio of 0.92 and a beta of 0.55. The company has a current ratio of 0.80, a quick ratio of 0.59 and a debt-to-equity ratio of 0.80. CVS Health Co. has a 12-month low of $52.71 and a 12-month high of $83.25.

CVS Health (NYSE:CVS) last issued its quarterly earnings data on Wednesday, November 6th. The pharmacy operator reported $1.09 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.08 by $0.01. CVS Health had a return on equity of 10.72% and a net margin of 1.36%. The firm had revenue of $95.43 billion during the quarter, compared to analysts’ expectations of $92.72 billion. During the same period in the previous year, the firm posted $2.21 earnings per share. CVS Health’s revenue was up 6.3% on a year-over-year basis. As a group, equities analysts expect that CVS Health Co. will post 5.48 EPS for the current fiscal year.

CVS Health Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Friday, November 1st. Investors of record on Monday, October 21st were paid a $0.665 dividend. The ex-dividend date of this dividend was Monday, October 21st. This represents a $2.66 dividend on an annualized basis and a yield of 4.77%. CVS Health’s payout ratio is 67.51%.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.